The Daily Philadelphian
For Philly fans, by Philly fans



Uncategorized

March 4, 2010

Cole, Jordan, Avant likely returning; Weaver close to new deal

More articles by »
Written by: Frank Ward
Tags: , , , , ,

On the day before the new NFL year and free agency begin, many teams are busy tendering restricted free agents to ensure that thy get something in return should the players leave.

The Eagles are no exception and have tendered WR Jason Avant, offensive lineman Nick Cole and LB Akeem Jordan at the second round level. Should any of them sign an offer sheet with another team that the Eagles choose not to match, they’ll receive a second round pick as compensation.

The team is also rumored to be nearing a long-term deal with Pro Bowl fullback Leonard Weaver. Bringing Weaver back is a necessity now that Brian Westbrook is gone and Darren Sproles is staying in San Diego. The Eagles need another body who can lug the ball, and Weaver showed that ability last year.

The Eagles and Leonard Weaver are close to a new, long term deal.

As far as Cole, Jordan and Avant, we’re not surprised any of them were tendered high-level deals. Cole’s versatility along the line guarantee his return. Jordan has showed glimpses of being a steady starter in the Eagles scheme. Avant thrived last year in the slot and proved to be the player the Eagles have long searched for to fill that role. It’s no surprise the Eagles wanted him back, no matter who is throwing him the ball next year.

The Birds also tendered Omar Gaither, Chris Gocong, Max Jean-Gilles and Sav Rocca at lower levels — think fifth round or below.

Honestly, with the exception of Gocong, we wouldn’t have tendered those players for a bag of used tissues. Jean-Gilles is a step above Stacey Andrews, which ain’t worth crap. Rocca is way too inconsistent and Gaither has lost a starting job three straight years.

Gocong has been linked to rumors involving the Patriots. Until last year, he had played well. We’re still not sure why he fell into Sean McDermott’s doghouse.







0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>